Enhancing the transmembrane permeability of resveratrol through a prodrug strategy

dc.contributor.authorBülbül, Bahadır
dc.contributor.authorBirgül, Kaan
dc.contributor.authorİlhan, Miray
dc.contributor.authorOral, Didem
dc.contributor.authorCoşkun, Göknil Pelin
dc.contributor.authorPolat, Duygu
dc.contributor.authorErdönmez, Demet
dc.date.accessioned2026-07-01T11:36:28Z
dc.date.available2026-07-01T11:36:28Z
dc.date.issued2026
dc.departmentDüzce Üniversitesi
dc.description.abstractThe “French Paradox” describes an epidemiological association between resveratrol (RSV) consumption and reduced incidence of certain chronic diseases. However, consuming large amounts of wine for one epidemiological reason, would be inappropriate due to the alcohol toxicity. Since RSV has poor pharmacokinetics, this study aimed to synthesize novel RSV ester derivatives, elucidate their structures, and evaluate their in vitro toxicity and transmembrane prodrug potential. For that purpose, considering the carbonate anion which is not a foreigner to the body, RSV carbonate esters were designed and synthesized. Then, the toxicity, IC50 values, and phase-I metabolic stability of the synthesized compounds were tested. Finally, the transmembrane properties of RSV carbonate esters were tested through a Franz Cell study. The results demonstrated that esterification of RSV hydroxyl groups markedly reduced intrinsic biological activity, consistent with the expected behavior of prodrug forms. Among the synthesized derivatives, compound 2 exhibited favorable release properties; however, its excessive metabolic stability limited efficient conversion to RSV, reducing its suitability for further development, whereas the other derivative was identified as a promising candidate for subsequent studies. © 2026 Marmara University Press.
dc.identifier.dergipark1839587
dc.identifier.doi10.12991/jrespharm.1839587
dc.identifier.endpage811
dc.identifier.issn2630-6344
dc.identifier.issue3
dc.identifier.scopus2-s2.0-105039413591
dc.identifier.scopusqualityQ3
dc.identifier.startpage795
dc.identifier.urihttps://doi.org/10.12991/jrespharm.1839587
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23058
dc.identifier.volume30
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMarmara University
dc.relation.ispartofJournal of Research in Pharmacy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20260623
dc.subjectanti-quorum sensing
dc.subjectcytotoxicity
dc.subjectprodrug
dc.subjectResveratrol
dc.subjecttransmembrane
dc.titleEnhancing the transmembrane permeability of resveratrol through a prodrug strategy
dc.typeArticle

Dosyalar